Atlas Trials

Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients

Clinical trial NCT00579514 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00579514
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerBladder CancerKidney CancerColon CancerProstate CancerLung CancerOvarian Cancer
Start date
2000-03-01
Primary completion
2027-03-01
Enrollment
21081

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.